GADOBUTROL

Generic: GADOBUTROL

Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
GADOBUTROLActive Substance
2022-11-17Original Approval

GADOBUTROL is FDA application ANDA215061, sponsored by HENGRUI PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
144 reports
2
PRURITUS
136 reports
3
NAUSEA
131 reports
4
URTICARIA
110 reports
5
VOMITING
92 reports
6
ERYTHEMA
85 reports
7
DIZZINESS
82 reports
8
HYPOTENSION
81 reports
9
COUGH
71 reports
10
RASH
69 reports